← All companies

PHAR

Pharming Group N.V.

PHAR Nasdaq Pharmaceutical Preparations EDGAR ↗

$9.82

-0.93 -8.65%

Key statistics

from XBRL data in SEC filings

Market cap

$6.89B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$9.62 – $21.34

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 30, 2026 6-K Jun 4, 2026 6-K May 28, 2026 6-K May 22, 2026 6-K May 7, 2026 6-K May 7, 2026 6-K Apr 16, 2026 20-F/A Apr 13, 2026 6-K Apr 2, 2026 20-F Apr 2, 2026 6-K Mar 27, 2026 6-K Mar 24, 2026 6-K Mar 12, 2026 6-K Feb 3, 2026 6-K Feb 2, 2026 6-K Jan 8, 2026 6-K Nov 6, 2025 6-K Oct 22, 2025 6-K Oct 6, 2025 6-K Oct 1, 2025 6-K Sep 10, 2025 6-K Sep 2, 2025 6-K Jul 31, 2025 6-K Jun 24, 2025 6-K Jun 11, 2025 6-K May 8, 2025 6-K Apr 30, 2025 6-K Apr 25, 2025 6-K Apr 23, 2025 6-K Apr 3, 2025 20-F Apr 3, 2025 6-K Mar 20, 2025 6-K Mar 13, 2025 6-K Mar 4, 2025 6-K Feb 20, 2025 6-K Feb 7, 2025 6-K Jan 21, 2025 6-K Jan 21, 2025 6-K Dec 16, 2024 6-K Dec 11, 2024